In last trading session, Gossamer Bio Inc (NASDAQ:GOSS) saw 1.25 million shares changing hands with its beta currently measuring 1.88. Company’s recent per share price level of $1.3 trading at -$0.06 or -4.41% at ring of the bell on the day assigns it a market valuation of $295.49M. That closing price of GOSS’s stock is at a discount of -19.23% from its 52-week high price of $1.55 and is indicating a premium of 49.23% from its 52-week low price of $0.66.
For Gossamer Bio Inc (GOSS), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.44. Splitting up the data highlights that, out of 10 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 3 suggested the stock as a Hold whereas 7 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Gossamer Bio Inc (NASDAQ:GOSS) trade information
Upright in the red during last session for losing -4.41%, in the last five days GOSS remained trading in the green while hitting it’s week-highest on Friday, 06/20/25 when the stock touched $1.3 price level, adding 9.72% to its value on the day. Gossamer Bio Inc’s shares saw a change of 57.37% in year-to-date performance and have moved 0.78% in past 5-day. Gossamer Bio Inc (NASDAQ:GOSS) showed a performance of 16.07% in past 30-days.
Wall Street analysts have assigned a consensus price target of 4 to the stock, which implies a rise of 67.5% to its current value. Analysts have been projecting 2 as a low price target for the stock while placing it at a high target of 5. It follows that stock’s current price would drop -53.85% in reaching the projected high whereas dropping to the targeted low would mean a loss of -53.85% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 40.29% during past 5 years. In 2025, company’s earnings growth rate is likely to be around -168.69% while estimates for its earnings growth in next 5 years are of 15.97%.
Gossamer Bio Inc (NASDAQ:GOSS)’s Major holders
NEA MANAGEMENT COMPANY, LLC is the top institutional holder at GOSS for having 18.09 million shares of worth $16.3 million. And as of 2024-06-30, it was holding 7.9979 of the company’s outstanding shares.
The second largest institutional holder is ARTAL GROUP S.A., which was holding about 13.31 million shares on 2024-06-30. The number of shares represents firm’s hold over 5.8832 of outstanding shares, having a total worth of $11.99 million.
